Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden · Delayed Price · Currency is SEK 3.660
-0.090 (-2.40%)
Jul 24, 2026, 5:22 PM CET
Sprint Bioscience AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 153.37 | 167.65 | 67.44 | 54.32 | 0.45 | 35.07 | |
Revenue Growth (YoY) | 141.25% | 148.60% | 24.15% | 12051.01% | -98.72% | 78.88% |
Cost of Revenue | 9.45 | 13.08 | 28.34 | 8.7 | 12.93 | 10.44 |
Gross Profit | 143.91 | 154.57 | 39.1 | 45.62 | -12.48 | 24.64 |
Selling, General & Admin | 54.81 | 55.69 | 56.28 | 45.07 | 47.44 | 49.47 |
Depreciation & Amortization Expenses | 1.08 | 1.07 | 0.96 | 0.45 | 0.62 | 0.59 |
Other Operating Expenses | 0.04 | 0.52 | 1.53 | 0.94 | 0.2 | 0.21 |
Total Operating Expenses | 55.93 | 57.28 | 58.77 | 46.46 | 48.26 | 50.26 |
Operating Income | 87.99 | 97.29 | -19.67 | -0.85 | -60.74 | -25.63 |
Interest Income | 2.02 | 0.65 | 1.43 | 0.79 | 0.68 | 0.86 |
Interest Expense | -5.52 | -6.21 | -0.04 | -0.39 | -0.11 | -0.31 |
Total Non-Operating Income (Expense) | -3.5 | -5.56 | 1.39 | 0.41 | 0.57 | 0.55 |
Pretax Income | -15.8 | 91.74 | -18.28 | -0.44 | -60.17 | -25.08 |
Net Income | -15.8 | 91.74 | -18.28 | -0.44 | -60.17 | -25.08 |
Net Income to Common | -15.8 | 91.74 | -18.28 | -0.44 | -60.17 | -25.08 |
Shares Outstanding (Basic) | 101 | 93 | 70 | 70 | 42 | 29 |
Shares Outstanding (Diluted) | 101 | 93 | 70 | 70 | 42 | 29 |
Shares Change (YoY) | 45.22% | 32.63% | 0.01% | 65.98% | 45.85% | 81.46% |
EPS (Basic) | 0.79 | 0.99 | -0.26 | -0.01 | -1.43 | -0.87 |
EPS (Diluted) | 0.78 | 0.98 | -0.26 | -0.01 | -1.43 | -0.87 |
Free Cash Flow | 70.42 | 83.44 | -24.65 | 20.42 | -59.05 | -42.82 |
Free Cash Flow Growth | -15.61% | - | - | - | - | - |
Free Cash Flow Per Share | 0.69 | 0.90 | -0.35 | 0.29 | -1.40 | -1.48 |
Gross Margin | 93.84% | 92.20% | 57.98% | 83.99% | -2792.62% | 70.24% |
Operating Margin | 57.37% | 58.03% | -29.17% | -1.56% | -13588.40% | -73.07% |
Profit Margin | -10.30% | 54.72% | -27.10% | -0.81% | -13460.90% | -71.52% |
FCF Margin | 45.91% | 49.77% | -36.56% | 37.59% | -13211.20% | -122.10% |
EBITDA | 89.07 | 98.37 | -18.71 | -0.4 | -60.12 | -25.04 |
EBITDA Margin | 58.07% | 58.67% | -27.75% | -0.73% | -13450.10% | -71.39% |
EBIT | 87.99 | 97.29 | -19.67 | -0.85 | -60.74 | -25.63 |
EBIT Margin | 57.37% | 58.03% | -29.17% | -1.56% | -13588.40% | -73.07% |